NZ Lymphoma / Leukaemia Research Review Issue 27

In this issue:

Leukaemia selection

Ibrutinib vs. ofatumumab in previously treated CLL
A comprehensive prognostic index for CLL
Targetable kinase-activating lesions in Ph-like ALL
Idelalisib for relapsed/ refractory CLL
QT interval prolongation with arsenic trioxide

Lymphoma selection

Rituximab maintenance in FL
A prospective study of MGZL
Restaging bone marrow in PET-negative DLBCL
Dose-intense ABVD without consolidation RT in advanced HL
R-CHOP ±bevacizumab in previously untreated DLBCL

Please login below to download this issue (PDF)